Literature DB >> 26095692

Clonality analysis of combined Brenner and mucinous tumours of the ovary reveals their monoclonal origin.

Yihong Wang1,2, Ren-chin Wu2,3, Lauren Ende Shwartz2, Lisa Haley2, Ming-tse Lin2, Ie-ming Shih2,4,5, Robert J Kurman2,4,5.   

Abstract

The derivation of ovarian intestinal-type mucinous tumours is not well established. Some are derived from teratomas but the origin of the majority is not clear. It has been recently proposed that the non-germ cell group may be derived from Brenner tumours, as the association of a mucinous tumour with a Brenner tumour is frequently observed. In order to explore the histogenesis of these neoplasms, we undertook a clonality analysis of the two components of ten combined Brenner and mucinous tumours using a human androgen receptor gene (HUMARA) assay. All eight informative cases of ten showed a concordant X-chromosome inactivation pattern between the two tumour components, indicative of a shared clonal origin (p = 0.0039). Microsatellite genotyping in five of the combined tumours displayed an identical heterozygous pattern with paired Fallopian tube tissue, indicative of a somatic cell origin. In addition, paired box protein 8, a highly sensitive Müllerian epithelial marker, was not detected by immunohistochemistry in either tumour component in any of the ten tumours, suggesting that this subset of mucinous tumours does not originate from Müllerian-derived epithelium. In conclusion, this study demonstrates that in combined mucinous and Brenner tumours, there is a shared clonal relationship between the two different tumour components and suggests that some pure mucinous tumours may develop from a Brenner tumour in which the Brenner tumour component becomes compressed and obliterated by an expanding mucinous neoplasm.
Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  Brenner tumour; HUMARA; X-chromosome inactivation; clonality analysis; histogenesis; mucinous tumour; ovary

Mesh:

Substances:

Year:  2015        PMID: 26095692      PMCID: PMC4703556          DOI: 10.1002/path.4572

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  20 in total

1.  Molecular analysis of clonality of sporadic angiomyolipoma.

Authors:  A Saxena; E C Alport; S Custead; L F Skinnider
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

2.  Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential.

Authors:  J Gu; L M Roth; C Younger; H Michael; F W Abdul-Karim; S Zhang; T M Ulbright; J N Eble; L Cheng
Journal:  J Natl Cancer Inst       Date:  2001-08-01       Impact factor: 13.506

3.  Different staining patterns of ovarian Brenner tumor and the associated mucinous tumor.

Authors:  Andres A Roma; Ramya P Masand
Journal:  Ann Diagn Pathol       Date:  2014-12-20       Impact factor: 2.090

4.  Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma.

Authors:  Trisha M Shattuck; William H Westra; Paul W Ladenson; Andrew Arnold
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

5.  Clonality analysis in tumours of women by PCR amplification of X-linked genes.

Authors:  H Peng; M Du; T C Diss; P G Isaacson; L Pan
Journal:  J Pathol       Date:  1997-02       Impact factor: 7.996

6.  Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations.

Authors:  J O Schorge; M G Muto; W R Welch; C A Bandera; S C Rubin; D A Bell; R S Berkowitz; S C Mok
Journal:  J Natl Cancer Inst       Date:  1998-06-03       Impact factor: 13.506

7.  Ovarian metastases of appendiceal tumors with goblet cell carcinoidlike and signet ring cell patterns: a report of 30 cases.

Authors:  Alexandra C Hristov; Robert H Young; Russell Vang; Anna V Yemelyanova; Jeffrey D Seidman; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2007-10       Impact factor: 6.394

8.  Ovarian Brenner tumors. I. Metaplastic, proliferating, and of low malignant potential.

Authors:  L M Roth; G Dallenbach-Hellweg; B Czernobilsky
Journal:  Cancer       Date:  1985-08-01       Impact factor: 6.860

9.  p63 expression in ovarian tumours: a marker for Brenner tumours but not transitional cell carcinomas.

Authors:  X Y Liao; W C Xue; D H Shen; H Y S Ngan; M K Siu; A N Cheung
Journal:  Histopathology       Date:  2007-10       Impact factor: 5.087

10.  Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.

Authors:  Russell Vang; Allen M Gown; Chengquan Zhao; Todd S Barry; Christina Isacson; Mary S Richardson; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2007-06       Impact factor: 6.394

View more
  14 in total

1.  Two types of primary mucinous ovarian tumors can be distinguished based on their origin.

Authors:  Michiel Simons; Femke Simmer; Johan Bulten; Marjolijn J Ligtenberg; Harry Hollema; Shannon van Vliet; Richarda M de Voer; Eveline J Kamping; Dirk F van Essen; Bauke Ylstra; Lauren E Schwartz; Yihong Wang; Leon F Massuger; Iris D Nagtegaal; Robert J Kurman
Journal:  Mod Pathol       Date:  2019-11-06       Impact factor: 7.842

Review 2.  The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Am J Pathol       Date:  2016-04       Impact factor: 4.307

3.  Mucinous borderline ovarian tumors: pathological and prognostic study at Salah Azaiez Institute.

Authors:  Ghada Sahraoui; Asma Fitouri; Lamia Charfi; Maha Driss; Maher Slimane; Monia Hechiche; Karima Mrad; Raoudha Doghri
Journal:  Pan Afr Med J       Date:  2022-04-29

4.  TNF-α expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis?

Authors:  Mamta Gupta; Ana Babic; Andrew H Beck; Kathryn Terry
Journal:  Hum Pathol       Date:  2016-04-08       Impact factor: 3.466

Review 5.  Ovarian and non-ovarian teratomas: a wide spectrum of features.

Authors:  Tsukasa Saida; Kensaku Mori; Tomohiko Masumoto; Sodai Hoshiai; Toshitaka Ishiguro; Masafumi Sakai; Tadashi Hara; Hiroyuki Ochi; Toyomi Satoh; Manabu Minami
Journal:  Jpn J Radiol       Date:  2020-09-01       Impact factor: 2.374

6.  Molecular Genetic Analysis of Ovarian Brenner Tumors and Associated Mucinous Epithelial Neoplasms: High Variant Concordance and Identification of Mutually Exclusive RAS Driver Mutations and MYC Amplification.

Authors:  Laura J Tafe; Kristen E Muller; Guruprasad Ananda; Talia Mitchell; Vanessa Spotlow; Sara E Patterson; Gregory J Tsongalis; Susan M Mockus
Journal:  Am J Pathol       Date:  2016-01-18       Impact factor: 4.307

Review 7.  Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.

Authors:  Ugo Testa; Eleonora Petrucci; Luca Pasquini; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2018-02-01

Review 8.  Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.

Authors:  Steffen Hauptmann; Katrin Friedrich; Raymond Redline; Stefanie Avril
Journal:  Virchows Arch       Date:  2016-12-27       Impact factor: 4.064

9.  A case report of an incidental Brenner tumor found after resection of a large ovarian mucinous neoplasm.

Authors:  Danielle Dougherty; Chibueze Onyemkpa; Michael Engel; Tolutope Oyasiji
Journal:  Int J Surg Case Rep       Date:  2018-05-26

Review 10.  Osteoclasts in Tumor Biology: Metastasis and Epithelial-Mesenchymal-Myeloid Transition.

Authors:  Kemal Behzatoglu
Journal:  Pathol Oncol Res       Date:  2021-04-30       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.